Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia
- PMID: 23873785
- DOI: 10.1002/ajh.23550
Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia
Similar articles
-
Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.Am J Hematol. 2010 Aug;85(8):608. doi: 10.1002/ajh.21719. Am J Hematol. 2010. PMID: 20658590 No abstract available.
-
Irreversible myelopathy associated with nelaribine in T-cell acute lymphoblastic leukemia.J Clin Oncol. 2013 Jul 1;31(19):e327-31. doi: 10.1200/JCO.2012.45.4728. Epub 2013 May 28. J Clin Oncol. 2013. PMID: 23715575 No abstract available.
-
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.Am J Hematol. 2009 Apr;84(4):228-30. doi: 10.1002/ajh.21365. Am J Hematol. 2009. PMID: 19260120 Review.
-
Nelarabine-associated reversible Guillain-Barré-like syndrome or myelopathy in an adult patient with primary refractory T-lymphoblastic lymphoma.Curr Probl Cancer. 2017 Mar-Apr;41(2):138-143. doi: 10.1016/j.currproblcancer.2016.11.005. Epub 2016 Nov 17. Curr Probl Cancer. 2017. PMID: 28169005 Review.
-
Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma.Br J Haematol. 2016 Jul;174(2):332-4. doi: 10.1111/bjh.13771. Epub 2015 Sep 25. Br J Haematol. 2016. PMID: 26403537 No abstract available.
Cited by
-
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication.Mediterr J Hematol Infect Dis. 2015 Mar 1;7(1):e2015025. doi: 10.4084/MJHID.2015.025. eCollection 2015. Mediterr J Hematol Infect Dis. 2015. PMID: 25745552 Free PMC article.
-
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.J Hematol Oncol. 2016 Oct 24;9(1):114. doi: 10.1186/s13045-016-0344-4. J Hematol Oncol. 2016. PMID: 27776559 Free PMC article.
-
Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases.Int J Hematol. 2023 Jun;117(6):933-940. doi: 10.1007/s12185-023-03539-5. Epub 2023 Jan 27. Int J Hematol. 2023. PMID: 36705847
-
Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant.Hemasphere. 2020 Jun 8;4(3):e379. doi: 10.1097/HS9.0000000000000379. eCollection 2020 Jun. Hemasphere. 2020. PMID: 32647798 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical